Sarasin & Partners LLP Purchases New Shares in GE HealthCare Technologies Inc. $GEHC

Sarasin & Partners LLP acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 14,200 shares of the company’s stock, valued at approximately $909,000.

Several other institutional investors have also added to or reduced their stakes in the stock. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at about $26,000. Optima Capital LLC bought a new position in GE HealthCare Technologies in the fourth quarter worth about $27,000. Godfrey Financial Associates Inc. bought a new position in GE HealthCare Technologies in the fourth quarter worth about $27,000. Montag A & Associates Inc. lifted its holdings in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after buying an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC boosted its position in GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Insider Activity at GE HealthCare Technologies

In other news, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was bought at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the acquisition, the director directly owned 1,618 shares in the company, valued at approximately $100,364.54. The trade was a ? increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Kevin Lobo acquired 10,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares in the company, valued at $921,817.34. This represents a 229.20% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Up 0.1%

GEHC stock opened at $70.31 on Friday. The business has a 50 day moving average of $64.53 and a 200 day moving average of $70.06. The firm has a market cap of $31.76 billion, a PE ratio of 16.13, a price-to-earnings-growth ratio of 2.03 and a beta of 0.69. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The business had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the previous year, the company posted $1.06 earnings per share. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.21%.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of research analyst reports. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday, July 30th. Barclays dropped their price target on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. Piper Sandler reiterated a “buy” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 29th. BTIG Research raised their price objective on GE HealthCare Technologies from $75.00 to $79.00 and gave the company a “buy” rating in a research report on Wednesday, July 29th. Finally, Mizuho reduced their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $77.73.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.